---
title: "PEG-MGF (PEGylated Mechano Growth Factor)"
canonical_url: https://peptidelibrary.app/library/peg-mgf
description: "PEGylated mechano-growth-factor (IGF-1Ec) analog sold for muscle-repair research. Not FDA-approved. WADA S2 (IGF / MGF)."
updated: 2026-11-07
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# PEG-MGF (PEGylated Mechano Growth Factor)

PEG-MGF (PEGylated Mechano Growth Factor), also called PEGylated MGF or PEG-IGF-1Ec, is a research peptide in the IGF-1 receptor agonist class. PEG-MGF is the mechano growth factor E-peptide with polyethylene glycol attached. Unmodified MGF has a very short circulating half-life, on the order of minutes, because it is small enough for rapid renal clearance and susceptible to proteolysis.

PEGylated mechano-growth-factor (IGF-1Ec) analog sold for muscle-repair research. Not FDA-approved. WADA S2 (IGF / MGF).

Also known as: PEGylated MGF, PEG-IGF-1Ec.

Categories: Fat Loss, Muscle/Recovery, Experimental.

## Classification

- Type: PEGylated IGF-1 splice variant / research
- Mechanism class: IGF-1 receptor agonist
- Development stage: Research only
- Regulatory class: Research compound, not FDA-approved

## Mechanism

PEG-MGF is the mechano growth factor E-peptide with polyethylene glycol attached. Unmodified MGF has a very short circulating half-life, on the order of minutes, because it is small enough for rapid renal clearance and susceptible to proteolysis. PEGylation increases hydrodynamic radius above the glomerular filtration threshold and shields the peptide from proteases, extending exposure. The underlying rationale is unchanged from MGF: the Ec E-peptide is proposed to activate muscle satellite cells after mechanical loading through a route independent of the IGF-1 receptor. Whether extending systemic exposure to a factor that normally acts locally after injury reproduces the same biology has not been established, and there is no human evidence.

Targets: IGF-1 receptor, Muscle satellite cells (proposed).

Origin: Synthetic PEGylated IGF-1Ec-related peptide.

## Properties

- Molecular formula: Large PEG-conjugated peptide (varies by manufacturer)
- Molecular weight: ≈8–10 kDa (PEG dependent)
- Half-life: Extended vs native MGF; no validated human PK

## Evidence

- Evidence level: Insufficient Evidence
- Highest documented: None documented
- Human trials: 0
- Controlled human trials: 0
- Preclinical sources: 0
- Latest source: 2026

No human dose is established for this compound.

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

### Studies

1. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026. 2026. Secondary report (review or programme summary), not a trial. Population: Not a study population: a review of clinical evidence and self-administration. Places PEG-MGF among unregulated peptides sold as research compounds. Limitations: Reported in research, not a controlled trial. [Source](https://pubmed.ncbi.nlm.nih.gov/42395176/)
2. Mechano-growth factor E-domain modulates cardiac contractile function through 14-3-3 protein interactomes. Front Physiol. 2022. 2022. Preclinical: animal or lab study. Population: Mice. Dose-dependent changes in cardiac contractile function. Research on a related compound, not this one. Limitations: Studied an analog, not PEG-MGF (PEGylated Mechano Growth Factor) itself; Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/36467694/)

## Safety

Side effects: Unknown PEGylated-peptide AEs.

Risks: WADA S2.

Human safety basis: No controlled human safety data

Key limitations: No established human dosage.; No controlled human trial results in the reviewed sources.; Not approved by the FDA for any use..

## Regulatory status

PEG-MGF (PEGylated Mechano Growth Factor) is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

- FDA status: Not Approved
- WADA status: Banned in Sport
- Availability: Research-Only

## Frequently asked questions

### What is PEG-MGF (PEGylated Mechano Growth Factor)?

PEGylated mechano-growth-factor (IGF-1Ec) analog sold for muscle-repair research. Not FDA-approved. WADA S2 (IGF / MGF).

### How does PEG-MGF (PEGylated Mechano Growth Factor) work?

PEG-MGF is the mechano growth factor E-peptide with polyethylene glycol attached. Unmodified MGF has a very short circulating half-life, on the order of minutes, because it is small enough for rapid renal clearance and susceptible to proteolysis.

### Is PEG-MGF (PEGylated Mechano Growth Factor) FDA approved?

No. PEG-MGF (PEGylated Mechano Growth Factor) is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use. FDA's compounding lists show 503A nomination: Previously in Category 2; nomination withdrawn by the nominators.

### What is the half-life of PEG-MGF (PEGylated Mechano Growth Factor)?

Reported half-life for PEG-MGF (PEGylated Mechano Growth Factor) is Extended vs native MGF; no validated human PK. Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

### Is PEG-MGF (PEGylated Mechano Growth Factor) banned in sport?

PEG-MGF (PEGylated Mechano Growth Factor) is recorded here as prohibited in sport. Athletes subject to anti-doping rules should check the current WADA Prohibited List directly, since it is revised annually and classifications change.

### What peptides are similar to PEG-MGF (PEGylated Mechano Growth Factor)?

Compounds most often compared with PEG-MGF (PEGylated Mechano Growth Factor) include IGF-1 (overview), Mecasermin, IGF-1 LR3 and IGF-1 DES. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

## References

- [WADA Prohibited List 2026](https://www.wada-ama.org/en/prohibited-list)
- [The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration — Front Endocrinol (Lausanne), 2026](https://pubmed.ncbi.nlm.nih.gov/42395176/)
- [Class-level evidence — Biological activity of the e domain of the IGF-1Ec as addressed by synthetic peptides — Hormones (Athens), 2014](https://pubmed.ncbi.nlm.nih.gov/24776619/)
- [Class-level evidence — The role of mechano-growth factor E peptide in the regulation of osteosarcoma — Oncol Lett, 2015](https://pubmed.ncbi.nlm.nih.gov/26622556/)
- [Class-level evidence — Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: characterization of the MGF E-peptide actions in vitro — Mol Med, 2011](https://pubmed.ncbi.nlm.nih.gov/20844834/)
